People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Pharmaceuticals, Biotechnology, Other Health Care, Medical Devices, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eyenovia, Inc. | — | Pharmaceuticals | Series C | $66.0M | $312.6M | 2016 |
| Iantrek, Inc. | — | Biotechnology | Series B | $58.2M | $152.4M | 2020 |
| Iantech, Inc. | — | Other Health Care | Series A | $12.2M | $246.7M | 2017 |
| SafeOp Surgical, Inc. | — | Medical Devices | Series A | $10.9M | $136.4M | 2012 |
| KYS Vision, Inc. | — | Other Technology | Seed | $2.2M | $5.7M | 2025 |
Tsontcho Ianchulev at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tsontcho Ianchulev on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Curt LaBelle | 2 | 7 |
| James Mazzo | 2 | 4 |
| Michael Haydin | 2 | 2 |
| Stephen Bloch | 1 | 15 |
| Richard Lindstrom | 1 | 13 |
| Ernest Mario | 1 | 9 |
| Anthony Sun | 1 | 8 |
| Brian Walsh | 1 | 7 |
| James L.L. Tullis | 1 | 6 |
| Marc-Andre Marcotte | 1 | 6 |
| BARRY BUTLER | 1 | 6 |
| FRED ESHELMAN | 1 | 5 |
| Charles Warden | 1 | 5 |
| Casey K. Tansey | 1 | 3 |
| Peter Pham | 1 | 3 |
| Glenn Rockman | 1 | 3 |
| John Gandolfo | 1 | 2 |
| Ali Tafreshi | 1 | 2 |
| Richard O'Brien | 1 | 2 |
| Kenneth Lee | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.